Impact of CD34(+) cell dose on outcomes of related allogeneic PBSCT in adult AML patients. Toda Y, Jo T, Arai Y, Harada K, et al. Br J Haematol 2026;209:210-221.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Toda Y, Jo T, Arai Y, Harada K, et al. Impact of CD34(+) cell dose on outcomes of related allogeneic PBSCT in adult AML patients. Br J Haematol 2026;209:210-221.
PMID: 42046860